Prevention of de novo hepatitis B virus infections: More seems no better

Liver Transplantation

Volumn 16, Issue 3, 2010, Pages 256-258

  Mutimer, David ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; HEPATITIS B ANTIBODY; LAMIVUDINE; TENOFOVIR;

DRUG RESISTANCE; EDITORIAL; GRAFT RECIPIENT; HEPATITIS B; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIVER TRANSPLANTATION; MONOTHERAPY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; SURVIVAL RATE; VIRUS REACTIVATION;

ANTIVIRAL AGENTS; DNA, VIRAL; DRUG THERAPY, COMBINATION; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULINS; LAMIVUDINE; LIVER; LIVER TRANSPLANTATION;

EID: 77749334514     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22026     Document Type: Editorial

References (8)

1. Yu L, Koepsell T, Manhart L, Ioannou G. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor. Liver Transpl 2009;15:1343-1350.
2. Perrillo R. Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen-positive liver donation: a survey of north American, European, and Asian-Pacific transplant programs. Liver Transpl 2009;15:223-232.
3. Saab S, Waterman B, Chi AC, Tong MJ. Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody positive donors: a systematic review. Liver Transpl 2010;16:300-307.
4. Mutimer DJ, Dusheiko G, Barrett C, Grellier L, Ahmed M, Anschuetz G, et al. Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up. Transplantation 2000;70:809-815.
5. Perrillo RP, Wright T, Rakela J, Levy G, Schiff E, Gish R, et al. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 2001;33:424-432.
6. Perrillo R, Hann H-W, Mutimer D, Willems B, Leung N, Lee WM, et al. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology 2004;126:81-90.
7. Schiff ER, Lai C-L, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and postliver transplantation patients. Hepatology 2003;38: 1419-1427.
8. Neff GW, O'Brien CB, Nery J, Shire N, Montalbano M, Ruiz P, et al. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Liver Transpl 2004;10:1372-1378.